Purpose:In patients with residual stone fragments, ultrasonic propulsion (UP) increased the fragment passage rate by 58% and reduced risk of relapse by 70% vs untreated controls with minor associated adverse events (AEs). This study presents a second, …
Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.
ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.
Purpose:Adults with low-grade intermediate-risk nonmuscle‐invasive bladder cancer commonly ask urologists how their routine/responsibilities will be affected by treatments, including the standard of care, transurethral resection…
Benjamin M. Brucker, MD, outlines considerations surrounding pre-procedure urinalysis, prophylactic periprocedural antibiotics, and optimal dosing regimens for onabotA administration.
Among the content is additional information on types of urinary incontinence, ways to control urgency, and frequently asked questions about a healthy bladder.
The investigational treatment is being evaluated in phase 1 clinical trials for solid tumors.
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
2023 Dues ($USD) $589 * $115 * $349, $314, $278 ◊ $150, $75, $50 ◊ $209 ^ $209 $209 $0 * Dues for Active/Associate members…
Investigators studied recent trends in chain ownership, physician ownership, and medical directorship of dialysis facilities in the US.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
